about
Mutational and Structural Analysis of KIR3DL1 Reveals a Lineage-Defining Allotypic Dimorphism That Impacts Both HLA and Peptide SensitivityDetection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infectionGenetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression.TET2 binds the androgen receptor and loss is associated with prostate cancer.Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency.Probabilistic bidirectional promoter switches: noncoding RNA takes control.Mouse Nkrp1-Clr gene cluster sequence and expression analyses reveal conservation of tissue-specific MHC-independent immunosurveillance.Interleukin-1 and interferon-γ orchestrate β-glucan-activated human dendritic cell programming via IκB-ζ modulation.LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-γ production by repressing β-catenin activation in dendritic cellsKiller immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promoters.Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHCCD8 T cells express randomly selected KIRs with distinct specificities compared with NK cellsCharacterization of KIR intermediate promoters reveals four promoter types associated with distinct expression patterns of KIR subtypes.Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough!Activating Receptor Signals Drive Receptor Diversity in Developing Natural Killer Cells.Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.Differential expression of the Ly49G(B6), but not the Ly49G(BALB), receptor isoform during natural killer cell reconstitution after hematopoietic stem cell transplantation.Analysis of Ly49 gene transcripts in mature NK cells supports a role for the Pro1 element in gene activation, not gene expression.Identification of a KIR antisense lncRNA expressed by progenitor cells.HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region.Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcriptsFunctional NK cell repertoires are maintained through IL-2Rα and Fas ligand.NF-kappa B p50/p65 affects the frequency of Ly49 gene expression by NK cells.Independent control of Ly49g alleles: implications for NK cell repertoire selection and tumor cell killing.Identification of an elaborate NK-specific system regulating HLA-C expression.Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction and Metabolism.Association of TNFRSF1B Promoter Polymorphisms with Human Disease: Further Studies Examining T-Regulatory Cells Are Required.Identification of trophoblast-specific elements in the HLA-C core promoterThe Human TET2 Gene Contains Three Distinct Promoter Regions With Differing Tissue and Developmental Specificities.A mutation in KIR3DS1 that results in truncation and lack of cell surface expressionMinimal PD-1 expression in mouse and human NK cells under diverse conditionsTuning of human NK cells by endogenous HLA-C expressionUnderstanding the tumour micro-environment communication network from an NOS2/COX2 perspectiveMolecular evolution of elements controlling HLA-C expression: Adaptation to a role as a killer-cell immunoglobulin-like receptor ligand regulating natural killer cell functionCCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcomeDifferential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III InterferonsTuning of NK-Specific HLA-C Expression by Alternative mRNA Splicing
P50
Q27681870-770B2F6F-B4C6-49A4-965F-2D1700528B3BQ28610733-2FDFED14-87FF-4E2C-B62C-9E3F1A167192Q33384422-E9E2FE66-4A93-491D-B87C-97B54E6173E9Q33563729-21DC304E-400C-4F63-9E7D-EFBBF39E75C1Q33702959-DCA6A60D-6DC3-4FCC-A792-285013753F9AQ34464408-CA3FADFF-3703-4866-B9D7-37A70032353DQ34506526-F8DC0FEA-9380-441A-A35A-7B50C1C1683CQ34634678-527D887F-7FFB-40AB-94F6-F7CB6AB52E15Q34722541-543D1B18-05D0-4F12-A8E2-45BAA00BF482Q35082263-19DE58C2-83BD-49E9-8039-FA390AD33D18Q35127969-D738FE62-F1E8-414B-A560-FB00D055DC86Q36352518-0AB8431B-E3F2-4E85-98CE-E009186CB92CQ36494136-0927D333-013A-480A-9534-13013F6DD9F7Q36652145-6E943057-2BAD-477F-AA4D-392D7A3A5667Q37158558-6F4628B0-20D5-43A9-9CBA-146B7AA322FEQ37164415-28D7B518-DAC1-4B92-9E6E-D43D4754E3D6Q37205272-CB3460D8-8906-4400-9255-4C48E2073E3FQ37227153-AD99D1AB-9B65-4CFA-8E6C-56D7D8585B42Q37255565-1FC5CACB-30D1-4057-8EB0-5D7CF5206E4CQ37480654-A4DECD01-9074-4154-9EA7-7557D98277C3Q37641177-9483EFB8-FF5E-4AD9-9F26-BCD3CDE3CFF5Q37692713-56DEFE75-DDD2-4423-893C-0D5BE779B305Q40104661-062F6319-53D5-4D10-B226-26F78E216BECQ40597332-81809CB2-7B7D-4A76-83E1-032946AB09F9Q48253044-CAAF82F7-1534-4CB5-9779-C618252B6069Q52326666-59062AA2-00A7-49F8-B613-7E879EDA3DB7Q54975838-69AEF764-F630-4EE5-8340-5563977413D4Q57055629-17987D25-FD8A-4BDC-8BEF-96F69E25F255Q64999279-AFA75354-A56C-4590-BCDE-C5E554A0FF57Q80769405-B2A5A506-E415-456E-967C-20299D11139FQ90064248-7FB60D73-4E2B-4D8B-91BE-AD39A60EF491Q90702538-2C441073-5EBC-4E80-A84B-EA8A0C4401ECQ91175269-60EA99A0-6F7D-47A7-9F66-E5C25B4779C1Q91559312-88E89038-7D1F-4F1A-815A-FF99042D256EQ92826937-A7F129D6-5828-41DE-BD5B-FFF5ED25C052Q93019950-C056FD16-6F52-4DF6-ACAA-9B6651A6462BQ93052180-D81E6906-3C63-4A30-B862-197B15BE40A2
P50
description
researcher, ORCID id # 0000-0002-7856-4266
@en
wetenschapper
@nl
name
Stephen K Anderson
@ast
Stephen K Anderson
@en
Stephen K Anderson
@nl
type
label
Stephen K Anderson
@ast
Stephen K Anderson
@en
Stephen K Anderson
@nl
prefLabel
Stephen K Anderson
@ast
Stephen K Anderson
@en
Stephen K Anderson
@nl
P106
P31
P496
0000-0002-7856-4266